Netherlands· NL-20516ac2ddc3
ITULAZAX 12 SQ-Bet, lyofilisaat voor sublinguaal gebruik
A baumpollen product containing betula verrucosa pollen, gestandaardizeerd allergenen extract, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Baumpollen is registered in 12 of 19 countries.
Countries holding a registration under ATC V01AA05 (baumpollen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Baumpollen · ATC V01AA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BETULA VERRUCOSA POLLEN, GESTANDAARDIZEERD ALLERGENEN EXTRACT
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- V01AA05
- ATC class
- Baumpollen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id127231//123556
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V01AA05
Baumpollen, as other registers publish it.
- DenmarkAlk (108) Betula VerrucosaALK-Abello A/S
- DenmarkAlk (108) Betula VerrucosaALK-Abello A/S
- SwitzerlandAllergovit Alnus/Corylus
- SwitzerlandAllergovit Alnus/Corylus
- SwitzerlandAllergovit Betula
- SwitzerlandAllergovit Betula
- SwitzerlandAllergovit Betula/Alnus/Corylus
- SwitzerlandAllergovit Betula/Alnus/Corylus
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd9c1656-fa4f-49c8-a116-34c341757b50 GET /v1/drugs/bd9c1656-fa4f-49c8-a116-34c341757b50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Lyofilisaat voor sublinguaal gebruik",
"route": "Sublinguaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123556_smpc.pdf",
"strength": null,
"atc_label": "Tree Pollen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127231",
"excipients": [
"GELATINE, AFKOMSTIG VAN VIS",
"MANNITOL (D-) (E 421)",
"NATRIUMHYDROXIDE (E 524)"
],
"substances": [
"BETULA VERRUCOSA POLLEN, GESTANDAARDIZEERD ALLERGENEN EXTRACT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127231.pdf",
"authorised_at": "2020/10/08",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "127231//123556",
"additional_monitoring": "N"
}See everything about baumpollen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.